α-Fucosidase as a novel convenient biomarker for cellular senescence

Cell Cycle

Volumn 12, Issue 12, 2013, Pages 1922-1927

  Hildebrand, Dominic G ^a   Lehle, Simon ^a   Borst, Andreas ^b   Haferkamp, Sebastian ^b   Essmann, Frank ^a   Schulze Osthoff, Klaus ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biomarker; Cellular senescence; Lysosome; fucosidase; galactosidase; glucuronidase

Indexed keywords

ALPHA LEVO FUCOSIDASE; BETA GALACTOSIDASE;

ARTICLE; CELL AGING; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ONCOGENE; UPREGULATION;

EID: 84879361184     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24944     Document Type: Article

References (41)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621; PMID:13905658; http://dx.doi.org/10. 1016/0014-4827(61)90192-6
2. Mallette FA, Ferbeyre G. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 2007; 6:1831-6; PMID:17671427; http://dx.doi.org/10.4161/cc.6.15.4516 (Pubitemid 47327900)
3. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi.org/10.4161/cc.8.24.10215
4. Adams PD. Healing and hurting: Molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009; 36:2-14; PMID:19818705; http://dx.doi.org/10.1016/j.molcel.2009.09.021
5. Schmidt S, Essmann F, Cirstea IC, Kuck F, Thakur HC, Singh M, et al. The centrosome and mitotic spindle apparatus in cancer and senescence. Cell Cycle 2010; 9:4469-73; PMID:21088502; http://dx.doi.org/10.4161/cc.9.22.13684
6. Acosta JC, Gil J. Senescence: A new weapon for cancer therapy. Trends Cell Biol 2012; 22:211-9; PMID:22245068; http://dx.doi.org/10.1016/j.tcb.2011. 11.006
7. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75:685-705; PMID:23140366; http://dx.doi.org/10.1146/annurev-physiol-030212- 183653
8. Braumüller H, Wieder T, Brenner E, Aßmann S, Hahn M, Alkhaled M, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494:361-5; PMID:23376950; http://dx.doi.org/10.1038/nature11824
9. Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The meaning of p16(ink4a) expression in tumors: Functional significance, clinical associations and future developments. Cell Cycle 2011; 10:2497-503; PMID:21775818; http://dx.doi.org/10.4161/cc.10.15.16776
10. Jänicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 2007; 6:407-13; PMID:17312393; http://dx.doi.org/10.4161/cc.6.4.3855 (Pubitemid 46393442)
11. Quijano C, Cao L, Fergusson MM, Romero H, Liu J, Gutkind S, et al. Oncogene-induced senescence results in marked metabolic and bioenergetic alterations. Cell Cycle 2012; 11:1383-92; PMID:22421146; http://dx.doi.org/10. 4161/cc.19800
12. Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6:472-6; PMID:16723993; http://dx.doi.org/10.1038/nrc1884
13. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10. 1016/S0092-8674(03)00401-X (Pubitemid 36724935)
14. Sulli G, Di Micco R, d'Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer 2012; 12:709-20; PMID:22952011; http://dx.doi.org/10.1038/nrc3344
15. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: Distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 2011; 124:68-81; PMID:21118958; http://dx.doi.org/10.1242/jcs.071340
16. Lawless C, Wang C, Jurk D, Merz A, Zglinicki Tv, Passos JF. Quantitative assessment of markers for cell senescence. Exp Gerontol 2010; 45:772-8; PMID:20117203; http://dx.doi.org/10.1016/j.exger.2010.01.018
17. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type-and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10:457-68; PMID:21248468; http://dx.doi.org/10.4161/cc.10.3.14707
18. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/ 10.1073/pnas.92.20.9363
19. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated ß-galactosidase is lysosomal ß-galactosidase. Aging Cell 2006; 5:187-95; PMID:16626397; http://dx.doi.org/10.1111/j.1474-9726. 2006.00199.x
20. Kurz DJ, Decary S, Hong Y, Erusalimsky JD. Senescence-associated (ß)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 2000; 113:3613-22; PMID:11017877
21. Yang NC, Hu ML. The limitations and validities of senescence associated-ß-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp Gerontol 2005; 40:813-9; PMID:16154306; http://dx.doi.org/10.1016/j.exger.2005.07.011
22. Untergasser G, Gander R, Rumpold H, Heinrich E, Plas E, Berger P. TGF-beta cytokines increase senescence-associated beta-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence. Exp Gerontol 2003; 38:1179-88; PMID:14580871; http://dx.doi.org/10.1016/j.exger.2003.08.008 (Pubitemid 37324429)
23. Coates PJ. Markers of senescence? J Pathol 2002; 196:371-3; PMID:11920730; http://dx.doi.org/10.1002/path.1073 (Pubitemid 34262846)
24. Severino J, Allen RG, Balin S, Balin A, Cristofalo VJ. Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res 2000; 257:162-71; PMID:10854064; http://dx.doi.org/10.1006/excr.2000. 4875 (Pubitemid 30324654)
25. Krishna DR, Sperker B, Fritz P, Klotz U. Does pH 6 beta-galactosidase activity indicate cell senescence? Mech Ageing Dev 1999; 109:113-23; PMID:10515661; http://dx.doi.org/10.1016/S0047-6374(99)00031-7 (Pubitemid 29397514)
26. Yegorov YE, Akimov SS, Hass R, Zelenin AV, Prudovsky IA. Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res 1998; 243:207-11; PMID:9716464; http://dx.doi.org/10.1006/excr.1998.4169 (Pubitemid 28397649)
27. Itahana K, Itahana Y, Dimri GP. Colorimetric detection of senescence-associated ß galactosidase. Methods Mol Biol 2013; 965:143-56; PMID:23296655; http://dx.doi.org/10.1007/978-1-62703-239-1-8
28. Winchester B, Barker C, Baines S, Jacob GS, Namgoong SK, Fleet G. Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin. Biochem J 1990; 265:277-82; PMID:2137330 (Pubitemid 20037700)
29. Janssen K, Pohlmann S, Jänicke RU, Schulze-Osthoff K, Fischer U. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 2007; 110:3662-72; PMID:17652622; http://dx.doi.org/10.1182/blood-2007-02-073213 (Pubitemid 350159635)
30. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436:642; PMID:16079833; http://dx.doi.org/10.1038/436642a (Pubitemid 41117258)
31. Georgakopoulou EA, Tsimaratou K, Evangelou K, Fernandez Marcos PJ, Zoumpourlis V, Trougakos IP, et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging (Albany NY) 2013; 5:37-50; PMID:23449538
32. Blagosklonny MV. Tumor suppression by p53 without apoptosis and senescence: Conundrum or rapalog-like gerosuppression? Aging (Albany NY) 2012; 4:450-5; PMID:22869016
33. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606
34. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, et al. A gene network regulating lysosomal biogenesis and function. Science 2009; 325:473-7; PMID:19556463
35. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012; 31:1095-108; PMID:22343943; http://dx.doi.org/10. 1038/emboj.2012.32
36. Peña-Llopis S, Brugarolas J. TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy. Cell Cycle 2011; 10:3987-8; PMID:22101272; http://dx.doi.org/10.4161/cc.10.23.18251
37. Chauhan S, Goodwin JG, Chauhan S, Manyam G, Wang J, Kamat AM, et al. ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy. Mol Cell 2013; 50:16-28; PMID:23434374; http://dx.doi.org/10.1016/j.molcel.2013.01.024
38. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94:727-37; PMID:9753320; http://dx.doi.org/10.1016/S0092-8674(00)81732-8 (Pubitemid 28436005)
39. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 2011; 108:3665-70; PMID:21307310; http://dx.doi.org/10. 1073/pnas.1019736108
40. McGuire JB, James TJ, Imber CJ, St Peter SD, Friend PJ, Taylor RP. Optimisation of an enzymatic method for beta-galactosidase. Clin Chim Acta 2002; 326:123-9; PMID:12417103; http://dx.doi.org/10.1016/S0009-8981(02)00332-7
41. Sperker B, Mürdter TE, Backman JT, Fritz P, Kroemer HK. Expression of active human beta-glucuronidase in Sf9 cells infected with recombinant baculovirus. Life Sci 2002; 71:1547-57; PMID:12127909; http://dx.doi.org/10. 1016/S0024-3205(02)01917-3 (Pubitemid 34808717)